Sign in to view content

Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use

Blake A. Cooper, MD MPH

Video
Published 2022

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)
Victor Hugo Gonzalez, MD
Annual Meeting Talks
2024
Hyalocyte Apoptosis in Vitreous Microparticles Suggest a Diabetic Vitreopathy
Harris C Sultan, MS, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

Diabetic Retinopathy

See more